|Company's Full Name:||Teleflex Incorporated|
|Trading Ticker Symbol:||TFX|
|Headquarter City/Country:||Pennsylvania, PA|
|Primary Industry Sector:||Health Care|
|Seconday Sub-sector:||Medical Dental Instruments|
|Main Business Areas:||Health Care, Medical Dental Instruments, Medical Instruments & Supplies|
|Dividend Payments:||Dividend History|
|Current Share Price:||$366.38|
|Previous Year's Closing Price:||$258.49|
|Percentage Price Change (YTD):||41.74%|
|Market Cap:||$16.91 billion|
|52-week Price Range:||$226.02 - $366.79|
|Dividend Per Share:||$1.36|
Teleflex Incorporated, incorporated on June 25, 1943, is a provider of medical technology products. The Company primarily designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for common diagnostic and therapeutic procedures in critical care and surgical applications. The Company operates through six segments: Vascular North America; Anesthesia North America; Surgical North America; Europe, Middle East and Africa (EMEA); Asia, and Original Equipment Manufacturer and Development Services (OEM). As of December 31, 2016, the Company manufactured its products at approximately 30 manufacturing sites, with manufacturing operations located in the Czech Republic, Germany, Malaysia, Mexico and the United States.
The Company's all others businesses include single-use respiratory, urology and cardiac care products, as well as capital equipment, which are provided to hospitals and other alternative channels of care. It also includes its Latin American business. Its respiratory products are used in a range of care settings. The products include oxygen therapy products, aerosol therapy products, spirometry products, and ventilation management products. The Company offers Hudson RCI brand. The Company's specialty product line of urology products provide bladder management. The product portfolio consists of a range of catheters, including Foley, intermittent, external and suprapubic; urine collectors; catheterization accessories, and products for operative endourology marketed under the Rusch brand name.
The Company's products in cardiac care product portfolio include diagnostic and intra-aortic balloon catheters and capital equipment. Its diagnostic catheters include thermodilution and wedge pressure catheters; specialized catheters used during the x-ray examination of blood vessels, such as Berman and Reverse Berman catheters; therapeutic delivery catheters, such as temporary pacing catheters; sheaths for femoral and trans-radial aortic access used in diagnostic and therapeutic procedures, and intra-aortic balloon (IAB), catheters. Capital equipment includes its intra-aortic balloon pump (IABP) consoles. The Company markets its cardiac care products under the Arrow brand name.
Vascular North America
The Company's Vascular North America segment consists of its North American vascular and interventional access businesses, which offers products that facilitate a range of critical care therapies and other applications. The vascular access products primarily consist of its Arrow branded catheters and related devices, including catheter positioning systems that are used in a range of procedures, including the administration of intravenous medications and other therapies, the measurement of blood pressure and the withdrawal of blood samples through a single puncture site.
The vascular access product portfolio principally consists of the products, including Arrow Central Venous Catheters (CVCs), Arrow EZ-IO Intraosseous Vascular Access System, Arrow Peripherally Inserted Central Catheters (PICCs), Arrow Jugular Axillo-subclavian Central Catheters (JACCs), Arrow Midline Catheters (Midlines), Arrow Catheter Tip Positioning Systems, Arrow Arterial Catheterization Sets, Arrow Multi-Lumen Access Catheters (MAC) and Arrow Percutaneous Sheath Introducers. The Company's CVCs are treated with solutions based on its ARROWg+ard or ARROWg+ard Blue Plus antimicrobial technology, which has been shown to reduce the risk of catheter related bloodstream infection. Its Chlorag+ard technology, available on its PICCs, JACCs and Midlines, provides antimicrobial and antithrombogenic protection on inner and outer catheter surfaces, as well as the fluid pathway of the catheter. Chlorag+ard technology is effective in reducing microbial colonization and thrombus accumulation on catheter surfaces.
The Company also offers various vascular access catheters in Maximal Barrier Precautions trays, which are designed to assist healthcare providers in complying with clinical guidelines for reducing catheter-related bloodstream infections. These trays are available for CVCs, PICCs and multi access catheters and include a full body drape, coated or non-coated catheters and other accessories. In addition, its ErgoPACK system offers clinicians a range of tray configurations with components packaged in the tray. The Company's interventional access products are used in a range of applications, including dialysis, oncology and critical care therapies. Its interventional access portfolio also includes several Arrow branded products, such as diagnostic and drainage kits, embolectomy balloons, and reinforced percutaneous sheath introducers. Its interventional access products include Arrow OnControl Powered Bone Marrow/Bone Access System, Arrow Trerotola Percutaneous Thrombectomy Device (PTD), Arrow Chronic Hemodialysis Catheters, ARROW-Clark VectorFlow Hemodialysis Catheter, Arrow Acute Hemodialysis Catheters and Arrow Polysite Low Profile Hybrid Ports.
Anesthesia North America
The Company's Anesthesia North America segment consists of its North American airway management and pain management products. The Company's airway management products and related devices consist of various products, including LMA Airways, LMA Atomization and RUSCH Endotracheal Tubes and Laryngoscopes. Its LMA laryngeal masks are used by anesthesiologists and emergency responders to establish an airway to channel anesthesia gas or oxygen to a patient's lungs during surgery or trauma. The LMA Protector Airway, its airway management device, is the first single-use laryngeal mask with a dual gastric drainage channel and pharyngeal chamber designed specifically to channel high volume, high pressure gastric contents away from the airway. It also integrates its Second Seal technology to isolate the respiratory tract from the digestive tract, reducing the risk of aspiration of gastric contents. The LMA Protector Airway also includes its Cuff Pilot technology, which enables clinicians to confirm that the inserted cuff is properly inflated and to monitor pressure levels.
The Company's LMA atomization portfolio includes products designed to facilitate atomized delivery of certain medications, including LMA MAD Nasal, an intranasal mucosal atomization device that is designed to provide a way to deliver medications approved for intranasal delivery to a patient's blood stream without an intravenous line or needle. The Company's offer a portfolio of products to facilitate and support endotracheal intubation to administer oxygen, and anesthetic gases in multiple settings (surgery, critical care and emergency settings). It also provides a range of products for laryngoscopy, a procedure that is primarily used to obtain a view of the airway to facilitate tracheal intubation during general anesthesia or cardiopulmonary resuscitation (CPR). Among these products is the Rusch DispoLED Laryngoscope Handle and Green Rusch Lite Blade, a single-use system designed to help facilities comply with standards designed to reduce the potential for patient cross-contamination associated with reusable devices during intubation. Its pain management products, which are designed for use in a range of surgical and obstetric procedures, consist of various products, including Arrow Epidural Catheters, Needles and Kits; Arrow Peripheral Nerve Block (PNB) Catheters, Pumps, Needles and Kits; AutoFuser Disposable Pain Pumps and Arrow EZ-IO System.
Surgical North America
The Company's surgical products are designed to provide surgeons with various devices for use in a range of surgical procedures. Its portfolio consists of single-use and reusable products, including Weck Ligation Systems, Weck EFx Fascial Closure Systems and Percutaneous Surgical Systems. Its Weck Ligation Systems features the Weck Ligating Clips and Hem-o-lok Ligating Clips. Its Weck fascial closure systems are used in laparoscopic surgical procedures and are intended to facilitate placement and withdrawal of suture loops to repair port site defects following laparoscopic surgery. Its Weck EFx endo fascial closure system is a port site closure device intended to minimize complications and costs associated with port-site herniation. The MiniLap family of surgical instruments consists of a ThumbGrip option on a 2.3 millimeters (mm) shaft or a pistol design called MiniGrip option on a 2.4mm shaft. Its other branded surgical products include its Weck Vista bladeless access ports, Deknatel sutures and its Pilling and Kmedic surgical instruments.
Europe, the Middle East and Africa
The Company's EMEA segment designs, manufactures and distributes medical devices primarily used in critical care, surgical applications and cardiac care and generally serves two end markets: hospitals and healthcare providers, and home health. The products offered by its EMEA segment are used in acute care settings for a range of diagnostic and therapeutic procedures and in general and specialty surgical applications, such as urology.
The Company's Asia segment, like its EMEA segment, designs, manufactures and distributes medical devices primarily used in critical care, surgical applications and cardiac care and generally serves hospitals and healthcare providers. The products offered by its Asia segment are used in acute care settings for a range of diagnostic and therapeutic procedures and in general and specialty surgical applications.
Original Equipment Manufacturer and Development Services
The Company's OEM segment designs, manufactures and supplies devices and instruments for other medical device manufacturers. Its OEM division, which includes the TFX OEM and Deknatel OEM brands, provides extrusions, diagnostic and interventional catheters, balloon sheath/dilator sets (introducers) and kits, sutures, performance fibers, and bioresorbable resins and fibers. The Company offers a portfolio of integrated capabilities, including engineering, material selection, regulatory affairs, prototyping, testing and validation, manufacturing, assembly and packing.
The Company competes with C. R. Bard, Inc., Medtronic plc, and Becton, Dickinson and Company.
550 E Swedesford Rd Ste 400
▶ ABIOMED (ABMD): ABIOMED, Inc., incorporated on June 4, 1987, is a provider of temporary percutaneous mechanical circulatory support devices. The Company offers care to heart failure patients. The Company operates in the ....See Detailed Company Profile and Dividend History.
▶ Accuray (ARAY): Accuray Incorporated, incorporated on February 22, 2001, is a radiation oncology company. The Company develops, manufactures, sells and supports treatment solutions. It develops, manufactures and markets medical devices used in ....See Detailed Company Profile and Dividend History.
▶ Alliqua BioMedical (ALQA): Alliqua BioMedical, Inc., incorporated on April 15, 2014, is a provider of wound care solutions. The Company operates in commercial wound care segment, which consists of approximately five product categories, ....See Detailed Company Profile and Dividend History.
▶ Alphatec (ATEC): Alphatec Holdings, Inc., incorporated on March 4, 2005, is a medical technology company. The Company through its subsidiary, Alphatec Spine, Inc. and its subsidiaries (Alphatec Spine), designs, develops, manufactures and ....See Detailed Company Profile and Dividend History.
▶ Amedica (AMDA): Amedica Corporation, incorporated on December 10, 1996, is a commercial biomaterial company. The Company is a vertically integrated silicon nitride orthopedic medical device manufacturer. It is focused on using its ....See Detailed Company Profile and Dividend History.
▶ AngioDynamics (ANGO): AngioDynamics, Inc., incorporated on July 30, 1992, designs, manufactures and sells a range of medical, surgical and diagnostic devices used by professional healthcare providers for vascular access, for the treatment ....See Detailed Company Profile and Dividend History.
▶ Anika Therapeutics (ANIK): Anika Therapeutics, Inc., incorporated on February 28, 1992, is an orthopedic medicines company. The Company is engaged in developing, manufacturing and commercializing products based on its hyaluronic acid (HA) technology. ....See Detailed Company Profile and Dividend History.
▶ Antares Pharma (ATRS): Antares Pharma, Inc. (Antares), incorporated on April 29, 2005, is a specialty pharmaceutical company that focuses on developing and commercializing self-administered parenteral pharmaceutical products and technologies. The Company develops, manufactures ....See Detailed Company Profile and Dividend History.
▶ Atossa Genetics (ATOS): Atossa Genetics Inc., incorporated on April 30, 2009, is a clinical-stage pharmaceutical company focused on the development of therapeutics and delivery methods for the treatment of breast cancer and other ....See Detailed Company Profile and Dividend History.
▶ AtriCure (ATRC): AtriCure, Inc., incorporated on October 31, 2000, is an atrial fibrillation (Afib) solutions company. The Company develops, manufactures, and sells devices designed primarily for the surgical ablation of cardiac tissue ....See Detailed Company Profile and Dividend History.
▶ Atrion (ATRI): Atrion Corporation (Atrion), incorporated on December 30, 1996, is engaged in developing and manufacturing products, primarily for medical applications. The Companys medical products range from fluid delivery devices to ophthalmic ....See Detailed Company Profile and Dividend History.
▶ Avinger (AVGR): Avinger, Inc., incorporated on March 8, 2007, is a commercial-stage medical device company. The Company designs, manufactures and sells image-guided, catheter-based systems that are used by physicians to treat patients ....See Detailed Company Profile and Dividend History.
▶ Baxter International (BAX): Baxter International Inc., incorporated on October 19, 1931, through its subsidiaries, provides a portfolio of essential renal and hospital products, including acute and chronic dialysis; sterile intravenous (IV) solutions; infusion ....See Detailed Company Profile and Dividend History.
▶ Becton Dickinson and (BDX): Becton, Dickinson and Company (BD), incorporated in November 1906, is a global medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory ....See Detailed Company Profile and Dividend History.
▶ Biolase (BIOL): BIOLASE, Inc. (BIOLASE), incorporated on February 10, 1987, is a medical device company that develops, manufactures, markets and sells laser systems in dentistry and medicine. The Company markets, sells, and ....See Detailed Company Profile and Dividend History.
▶ Biomerica (BMRA): Biomerica, Inc., incorporated on September 22, 1971, is a biomedical company, which develops, manufactures and markets medical diagnostic products for the early detection and monitoring of chronic diseases and medical ....See Detailed Company Profile and Dividend History.
▶ Biostage (BSTG): Biostage, Inc., formerly Harvard Apparatus Regenerative Technology, Inc., incorporated on May 3, 2012, is a biotechnology company. The Company is engaged in developing bioengineered organ implants based on its Cellframe ....See Detailed Company Profile and Dividend History.
▶ Boston Scientific (BSX): Boston Scientific Corporation, incorporated on June 22, 1979, is a developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. The Company offers ....See Detailed Company Profile and Dividend History.
▶ Bovie Medical (BVX): Bovie Medical Corporation (Bovie), incorporated on December 3, 1982, is an energy-based medical device company. The Company is also engaged in the design, development and manufacturing of electrosurgical equipment by ....See Detailed Company Profile and Dividend History.
▶ Cantel Medical (CMD): Cantel Medical Corp., incorporated on August 16, 1963, is a provider of infection prevention products and services in the healthcare market. The Companys operating segments include Endoscopy; Water Purification and ....See Detailed Company Profile and Dividend History.
... See Full List of All Stocks of Medical Dental Instruments Sector.
▶ Stocks of Sector
▶ Stocks of Biotech Sector
▶ Stocks of Biotech Apparatus Sector
▶ Stocks of Biotech Diagnostics Sector
▶ Stocks of Biotech Products Sector
▶ Stocks of Biotech Research Sector
▶ Stocks of Drug Delivery Sector
▶ Stocks of Drug Development Sector
▶ Stocks of Drug Manufacturer Sector
▶ Stocks of Health Care Sector
▶ Stocks of Health Care Equipment and Services Sector
▶ Stocks of Hospital and Nursing Management Sector
▶ Stocks of Industrial Specialties Sector
▶ Stocks of Major Pharmaceuticals Sector
▶ Stocks of Medical Dental Instruments Sector
▶ Stocks of Medical Electronics Sector
▶ Stocks of Medical Nursing Services Sector
▶ Stocks of Medical Products Sector
▶ Stocks of Medical Specialities Sector
▶ Stocks of Ophthalmic Goods Sector
▶ Stocks of Other Pharmaceuticals Sector
▶ Stocks of Precision Instruments Sector
▶ Stocks of Sector
▶ Stocks of Basic Industries Sector
▶ Stocks of Basic Materials Sector
▶ Stocks of Capital Goods Sector
▶ Stocks of Communication Services Sector
▶ Stocks of Consumer Cyclical Sector
▶ Stocks of Consumer Defensive Sector
▶ Stocks of Consumer Durables Sector
▶ Stocks of Consumer Non-Durables Sector
▶ Stocks of Consumer Services Sector
▶ Stocks of Energy Sector
▶ Stocks of Finance Sector
▶ Stocks of Financial Services Sector
▶ Stocks of Health Care Sector
▶ Stocks of Industrials Sector
▶ Stocks of Miscellaneous Sector
▶ Stocks of Public Utilities Sector
▶ Stocks of Real Estate Sector
▶ Stocks of Services Sector
▶ Stocks of Technology Sector
▶ Stocks of Transportation Sector
▶ Stocks of Utilities Sector